Ecron Acunova CRO Expands its Clinical Research Center for Drug Development
Ecron Acunov announced expansion of their Mangalore Clinical Pharmacology Unit to a 80 bed facility. The Research Center was dedicated by Dr. Ramdas M Pai, Chancellor, Manipal University.
This expansion caters to the growing needs of its global clients in Pharmaco-Kinetic and Pharmaco Dynamic studies. This takes total bed capacity to 176 units in research centers at Mangalore, Manipal, and Bangalore. Drug research involves analyzing the activity of the drug in plasma using spectroscopy. Highly sophisticated spectrometers have been added. Speaking on the occasion Dr. Ramdas Pai said, "I commend the safe conduct of studies for Indian and global companies, leveraging the scientific and clinical talent of India. It is heartening to note that studies conducted at the center, got US FDA approval, leading to launch of drugs for treatment of HIV, cancer etc."
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
